Axion BioSystems creates tools for understanding human heart and brain activity. The company’s novel platform is a proprietary microelectronic system that enables precise manipulation of human cells and tissue.
Axion’s flagship product, the Maestro, is the first commercially available multiple micro electrode array (MEA). This in vitro tool, which models brain activity in a dish, is used to evaluate drug toxicity, develop lead compounds and create phenotypic models.
Axion’s tools offer a range of biomedical applications — life science instrumentation, medical diagnostics and implantable devices — with relevance to the pharmaceutical and biotech industries and academic and government research.
Company website: Axion Biosystems
Back to companies
Location: United States, Georgia, Atlanta
Total raised: $8M
Investors 3
Date | Name | Website |
- | Georgia Re... | gra.org |
- | GRA Ventur... | graventure... |
- | Summa Equi... | summaequit... |
Funding Rounds 1
Date | Series | Amount | Investors |
26.09.2018 | - | $8M | - |
Mentions in press and media 5
Date | Title | Description | Source |
31.01.2023 | Axion BioSystems Launches New High-Throughput Live-Cell Imag... | Axion BioSystems announces the addition of the Omni Pro 12 to the Omni live-cell imaging product fam... | aithority.... |
16.07.2021 | Summa Equity acquires Axion BioSystems, to accelerate unders... | Summa Equity acquires Axion BioSystems, to accelerate understanding of cell behaviour in drug discov... | news.cisio... |
16.07.2021 | The continued divvying up of the Weinstein Company | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
16.07.2021 | The continued divvying up of the Weinstein Company | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
15.07.2021 | Summa Equity acquires Axion BioSystems, to accelerate unders... | Summa Equity Fund II has acquired Axion BioSystems, a US life science tools business specializing in... | summaequit... |